Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT01592721 · COMPLETED
Trial details
- NCT number
- NCT01592721
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2022-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.